EE200100048A - Substituted phenylamidines with antithrombotic effects - Google Patents

Substituted phenylamidines with antithrombotic effects

Info

Publication number
EE200100048A
EE200100048A EEP200100048A EEP200100048A EE200100048A EE 200100048 A EE200100048 A EE 200100048A EE P200100048 A EEP200100048 A EE P200100048A EE P200100048 A EEP200100048 A EE P200100048A EE 200100048 A EE200100048 A EE 200100048A
Authority
EE
Estonia
Prior art keywords
antithrombotic effects
substituted phenylamidines
phenylamidines
substituted
antithrombotic
Prior art date
Application number
EEP200100048A
Other languages
Estonian (et)
Inventor
Himmelsbach Frank
Guth Brian
Schubert Hans-Dieter
Original Assignee
Boehringer Ingelheim Pharma Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Kg filed Critical Boehringer Ingelheim Pharma Kg
Publication of EE200100048A publication Critical patent/EE200100048A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/49Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
    • C07C211/50Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200100048A 1998-07-23 1999-07-20 Substituted phenylamidines with antithrombotic effects EE200100048A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19833105A DE19833105A1 (en) 1998-07-23 1998-07-23 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents
PCT/EP1999/005161 WO2000005207A1 (en) 1998-07-23 1999-07-20 Substituted phenylamidines with antithrombotic action

Publications (1)

Publication Number Publication Date
EE200100048A true EE200100048A (en) 2002-06-17

Family

ID=7875009

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100048A EE200100048A (en) 1998-07-23 1999-07-20 Substituted phenylamidines with antithrombotic effects

Country Status (30)

Country Link
EP (1) EP1102746B1 (en)
JP (1) JP3629208B2 (en)
KR (1) KR20010072046A (en)
CN (1) CN1310708A (en)
AR (1) AR019462A1 (en)
AT (1) ATE240297T1 (en)
AU (1) AU5285399A (en)
BG (1) BG105159A (en)
BR (1) BR9912321A (en)
CA (1) CA2337413A1 (en)
CO (1) CO5080745A1 (en)
DE (2) DE19833105A1 (en)
DK (1) DK1102746T3 (en)
EA (1) EA200100106A1 (en)
EE (1) EE200100048A (en)
ES (1) ES2199587T3 (en)
HK (1) HK1038750A1 (en)
HU (1) HUP0103327A3 (en)
ID (1) ID27205A (en)
IL (1) IL140774A0 (en)
NO (1) NO20010354D0 (en)
PL (1) PL345624A1 (en)
PT (1) PT1102746E (en)
SK (1) SK1052001A3 (en)
TR (1) TR200100182T2 (en)
TW (1) TW460461B (en)
UY (1) UY25621A1 (en)
WO (1) WO2000005207A1 (en)
YU (1) YU3701A (en)
ZA (1) ZA200100363B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002510A1 (en) 2000-01-21 2001-07-26 Boehringer Ingelheim Pharma New phenylamidine compounds are useful for the treatment of thrombosis, cerebrovascular disorders, heart infarction, arteriosclerosis, osteoporosis, tumor metastasis, shock and diabetes
US8399678B2 (en) * 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
EP2522662A1 (en) * 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
CN105330568B (en) * 2015-11-27 2017-05-10 山东省医学科学院药物研究所 Preparation method for p-aminobenzamidine hydrochloride
CN105732433A (en) * 2016-04-13 2016-07-06 山东新华制药股份有限公司 Refining method of Dabigatran etexilate intermediate condensation compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT77309A (en) * 1994-12-01 1998-03-30 Toyama Chemical Co. Ltd. Novel 2,3-diketopiperazine derivative or salt thereof, pharmaceutical compositions containing them and their use
DE19515500A1 (en) * 1995-04-27 1996-10-31 Thomae Gmbh Dr K Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for their preparation

Also Published As

Publication number Publication date
HUP0103327A2 (en) 2002-01-28
HUP0103327A3 (en) 2003-11-28
ES2199587T3 (en) 2004-02-16
AR019462A1 (en) 2002-02-20
BR9912321A (en) 2001-04-24
EP1102746A1 (en) 2001-05-30
NO20010354L (en) 2001-01-22
BG105159A (en) 2001-07-31
PL345624A1 (en) 2002-01-02
JP2002521363A (en) 2002-07-16
PT1102746E (en) 2003-10-31
TR200100182T2 (en) 2001-07-23
HK1038750A1 (en) 2002-03-28
CN1310708A (en) 2001-08-29
KR20010072046A (en) 2001-07-31
UY25621A1 (en) 2001-12-28
DE19833105A1 (en) 2000-01-27
NO20010354D0 (en) 2001-01-22
DK1102746T3 (en) 2003-09-08
TW460461B (en) 2001-10-21
ATE240297T1 (en) 2003-05-15
YU3701A (en) 2003-01-31
EP1102746B1 (en) 2003-05-14
DE59905568D1 (en) 2003-06-18
CA2337413A1 (en) 2000-02-03
EA200100106A1 (en) 2001-08-27
IL140774A0 (en) 2002-02-10
AU5285399A (en) 2000-02-14
SK1052001A3 (en) 2001-08-06
WO2000005207A1 (en) 2000-02-03
JP3629208B2 (en) 2005-03-16
ZA200100363B (en) 2001-07-18
ID27205A (en) 2001-03-08
CO5080745A1 (en) 2001-09-25

Similar Documents

Publication Publication Date Title
ATE341990T1 (en) SIGMIDOSCOPE
DE69920962D1 (en) POLYCARBONATABMISCHUNG
DE59911453D1 (en) AKTIVKOHLEFILTER
DE59912371D1 (en) Slipformer
DE59901560D1 (en) RETROGRADER TIBIANAGEL
DE59902874D1 (en) BUCHSENKONTAKT
DE59907306D1 (en) FADENCHANGIERUNG
DE59906931D1 (en) EXZENTERZAHNRADGETRIEBE
NO993443L (en) Kabin Structure
ID24221A (en) PATRUM PLACE
DE59911683D1 (en) Fahrzeugschliessanlage
DK1087992T3 (en) Antithrombotic compounds
ATE262513T1 (en) BENZOYLPYRIDAZINE
DE59903966D1 (en) EXZENTERZAHNRADGETRIEBE
DE59908769D1 (en) N-arylsulfonyl-AMINO-OMEGA-AMIDE
DE59903106D1 (en) TRIPODE-CVJ
DE59901046D1 (en) Methylcyclotetradec-5-en-1-one
DE59908057D1 (en) Underdruckhandhabungseinrichung
DE59807217D1 (en) NADELLAGER
FI980759A0 (en) Taetningskonstruktion Foer suglaodan i en sugvals
DE19842103B4 (en) Stanznietzuführung
DE59808995D1 (en) endomicroscope
EE200100048A (en) Substituted phenylamidines with antithrombotic effects
DE59900612D1 (en) Dispersionsazofarbstoffmischungen
DE59903616D1 (en) Rollenwicklerwalze